Multiple myeloma and second malignancies

Journal article

Peer reviewed

Monika Engelhardt, Ralph Wäsch, Ola Landgren, Martina Kleber and Carl Ola Landgren

Clinical lymphoma, myeloma and leukemia, Vol.14(2), pp.98-101

2014-04

PMID: 24445186

Abstract

Female

Humans

Male

Multiple Myeloma - drug therapy

Neoplasms, Second Primary - diagnosis

Registries - statistics & numerical data

Thalidomide - analogs & derivatives

Thalidomide - therapeutic use

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Multiple myeloma and second malignancies
Creators: Monika Engelhardt - University Medical Center Freiburg
Ralph Wäsch - University Medical Center Freiburg
Ola Landgren - Multiple Myeloma Section, Metabolism Branch, National Cancer Institute, Bethesda, MD.
Martina Kleber - University Medical Center Freiburg
Carl Ola Landgren - Miller School of Medicine
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.14(2), pp.98-101
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 24445186
Record Identifier: 991031713638802976